Your browser doesn't support javascript.
loading
The Incidence of Psychiatric Medication Use and Its Effect on Intraoperative Bleeding in Facial Cosmetic Patients.
Harvey, Donald; Punjabi, Ayesha; Okada, Haruko; Zwiebel, Samantha; Riazi, Hooman; Guyuron, Bahman.
Afiliação
  • Harvey D; Vega Plastic Surgery, Rochester, NY, USA.
  • Punjabi A; The Department of Plastic Surgery, University Hospital Case Medical Center, Cleveland, OH, USA. aap71@case.edu.
  • Okada H; , 29001 Cedar Road, Lyndhurst, OH, 44124, USA. aap71@case.edu.
  • Zwiebel S; The Division of Plastic Surgery, OhioHealth Grant Medical Center, Columbus, OH, USA.
  • Riazi H; The Department of Psychiatry, University of Kentucky, Lexington, KY, USA.
  • Guyuron B; The Department of Plastic Surgery, University Hospital Case Medical Center, Cleveland, OH, USA.
Aesthetic Plast Surg ; 42(1): 147-150, 2018 Feb.
Article em En | MEDLINE | ID: mdl-29067471
ABSTRACT

PURPOSE:

Psychiatric medications, particularly the selective serotonin reuptake inhibitors, have been associated with increased surgical bleeding. This study aims to compare intraoperative surgical bleeding between cosmetic surgery patients who are and are not taking psychiatric medications.

METHODS:

The charts of 392 consecutive patients who underwent cosmetic facial surgery at the senior author's practice were reviewed. Independent variables included self-reported psychiatric history, psychiatric diagnoses, and psychiatric medications as documented in the preoperative history and physical examination. The primary endpoint was administration of desmopressin (DDAVP), our proxy for increased surgical bleeding. Significant predictors of these endpoints were determined via Chi-squared testing.

RESULTS:

One hundred and seventeen patients had a psychiatric diagnosis (30%), and 129 patients were taking some class of psychiatric medication (33%). Seventy-two patients received DDAVP (18%). A psychiatric diagnosis did not predict DDAVP administration (14.3% for patients with a psychiatric diagnosis vs. 20.88% for those without, p = 0.14). The use of a psychiatric medication was not associated with DDAVP administration (14.7 vs. 21%, p = 0.14). Male gender significantly predicted DDAVP administration (27.8 vs. 16.9% for females, p = 0.04).

CONCLUSION:

The use of psychiatric medications does not predict increased intraoperative surgical bleeding. This is useful given the prevalence of psychiatric medication use among this patient population and obviates the need for discontinuation of these medications, which otherwise could be consequential. LEVEL OF EVIDENCE IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ritidoplastia / Transtornos do Humor / Desamino Arginina Vasopressina / Hemorragia / Antidepressivos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Aesthetic Plast Surg Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ritidoplastia / Transtornos do Humor / Desamino Arginina Vasopressina / Hemorragia / Antidepressivos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Aesthetic Plast Surg Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos